Zacks Industry Rank Analysis Highlights: Stericycle, Quest Diagnostic, Biogen Idec, AmeriSourceBergen, Abbott Labs, Tesoro, AK Steel, Nucor, United States Steel, Fifth Third, Zions Bancorp, Suntrust Banks, Franklin Resources and Micron

Chicago, IL – June 25, 2009 – Zacks.com releases the latest Zacks Industry Rank. Stocks featured in this week's analysis include Stericycle (SRCL), Quest Diagnostic (DGX - Snapshot Report), Biogen Idec (BIIB - Analyst Report), AmeriSourceBergen (ABC - Analyst Report), Abbott Labs (ABT - Analyst Report), Sunoco (SUN - Analyst Report), Tesoro (TSO - Analyst Report), AK Steel (AKS - Analyst Report), Nucor (NUE - Analyst Report), United States Steel (X - Analyst Report), Fifth Third (FITB - Analyst Report), First Horizon National (FHN - Snapshot Report), Zions Bancorp (ZION - Analyst Report), Suntrust Banks (STI - Snapshot Report), Franklin Resources (BEN - Snapshot Report), AllianceBernstein Holding (AB - Snapshot Report), Texas Instruments (TXN - Analyst Report), National Semiconductor (NSM - Analyst Report) and Micron (MU - Snapshot Report).

Zacks Industry Rank Analysis is written by Charles Rotblut, CFA, Senior Market Analyst for Zacks.com.

This Week: Second-Quarter Earnings Outlook

Second-quarter earnings will be ugly.

Median EPS is projected to drop 21.2%. Nearly 75% of S&P 500 members are forecast to report earnings that are lower than a year ago. 62 companies are projected to have lost money.

These numbers are not unexpected given that we remain in the midst of a recession. They could even prove to be too pessimistic given the propensity of companies to surprise and the relative improvements in economic conditions.

Growth Industries

The one sector projected to show the strongest growth is also the one with the highest political risk - Medical. The majority of medical care providers, health insurers, pharmacy benefit managers and drug companies should report a year-over-year increase in profits.

Zacks #2 Rank ("buy") stocks expected to report growth include Stericycle (SRCL) (+14.4%), Quest Diagnostic (DGX - Snapshot Report) (+13%), Biogen Idec (BIIB - Analyst Report) (+9.8%), AmeriSourceBergen (ABC - Analyst Report) (+7%) and Abbott Labs (ABT - Analyst Report) (+5%).

The medical sector is less economically sensitivity than other sectors. Plus, the expansion of Medicare Part D has made prescriptions more affordable.

The obvious risk, however, is the ongoing discussions about healthcare reform. Though these talks have no impact on current earnings, they could significantly impact future earnings.

Another area of growth is refining. Sunoco (SUN - Analyst Report) and Tesoro (TSO - Analyst Report) are expected to have increased second-quarter profits by 46% and 223.7% respectively. These impressive numbers are a reflection of last year's spike in oil prices.

The problem is that the recent rise in oil prices is hurting margins.

Full-year earnings estimates are falling for both companies, which means even if TSO and other refiners top expectations, guidance could be weak. Our oil analyst, Sheraz Mian, downgraded TSO last month to a long-term sell recommendation.

Industries With Profit Declines

Since most industries will show a year-over-year decline in median EPS growth, I'm going to focus on 2 industries with the biggest projected declines.

Steel is among the worst, with 3 companies - AK Steel (AKS - Analyst Report), Nucor (NUE - Analyst Report) and United States Steel (X - Analyst Report) - projected to report year-over-year declines in excess of 130% each.

These companies are facing very tough comparables because of last year's commodity bubble. Though AK Steel (AKS - Analyst Report) said on Tuesday that its results would show a sequential quarterly improvement, any narrower loss would be because of cost-cutting and not improving business conditions.

NUE is a Zacks #4 Rank ("sell") stock. AKS and X are Zacks #3 Rank ("hold") stocks.

Banks will not fare much better. Regional banks are forecast to report a median decline of 98.7% and the large banks are projected to report a 61.3% decrease. Though the government has deemed some banks too big to fail, the FDIC has shut down 40 since the start of the year.

Home foreclosures have yet to peak and credit card default rates are rising. At the same, the ongoing housing slump and tighter credit standards continue to hurt mortgage originations. And though Q208 was not great for the banks, the credit crunch was not as severe as what was witnessed in the second half of 2009.

The largest year-over-year declines is likely to come from Fifth Third (FITB - Analyst Report) (-689.3%, the bank is swinging from a profit, on an adjusted basis, to a loss), First Horizon National (FHN - Snapshot Report) (-211.6%), Zions Bancorp (ZION - Analyst Report) (-189.7%) and Suntrust Banks (STI - Snapshot Report) (-166%).

Where To Look For Surprises

There are 2 industry groups that I would keep an eye on for potential positive surprises - Finance-Investment Management and Electronic-Semiconductor.

As I said last week, profit forecasts are rising for several mutual fund managers, including Franklin Resources (BEN - Snapshot Report) and AllianceBernstein Holding (AB - Snapshot Report).

Positive mutual fund inflows and growth in assets under management have some analysts rethinking their forecasts. However, since many of the covering analysts have not followed suit, the consensus earnings estimates could prove to be too low.

The semiconductor industry appears to be in the early stages of a recovery. Therefore, while profits will be terrible (down -61.5%), they could very well be better than forecast.

Texas Instruments (TXN - Analyst Report) raised its Q2 forecast earlier this month, SEMI's (a chip industry association) book-to-bill ratio has increased for 3 consecutive months and analysts have been revising their full-year forecasts higher. Plus, National Semiconductor (NSM - Analyst Report) beat by 18 cents when it reported last week.

We'll get another early indicator of how chip earnings look relative to expectations this afternoon, when Micron (MU - Snapshot Report) reports. The consensus earnings estimate calls for a loss of 43 cents per share.

Zacks "Profit from the Pros " e-mail newsletter offers continuous coverage of the industries and the stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=5611.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3:1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit From the Pros by going to http://at.zacks.com/?id=5610.

Follow us on Twitter: http://twitter.com/ZacksInvestment

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact: Charles Rotblut, CFA
Company: Zacks.com
Phone: 312-265-9352
Email: pr@zacks.com
Visit: www.zacks.com